Gazaignes S - Search Results

1

[Intermittent prolonged fever triggered by efforts].

Froissart A, Gazaignes S, Gellen-Dautremer J, Leflon-Guibout V, Iakovlev G, Zarrouk V, Lefort A, Fantin B. Froissart A, et al. Among authors: gazaignes s. Rev Med Interne. 2012 Sep;33(9):519-21. doi: 10.1016/j.revmed.2012.06.003. Epub 2012 Jul 4. Rev Med Interne. 2012. PMID: 22766160 French.

2

Molecular characterization of the 17D-204 yellow fever vaccine.

Salmona M, Gazaignes S, Mercier-Delarue S, Garnier F, Korimbocus J, Colin de Verdière N, LeGoff J, Roques P, Simon F. Salmona M, et al. Among authors: gazaignes s. Vaccine. 2015 Oct 5;33(41):5432-5436. doi: 10.1016/j.vaccine.2015.08.055. Epub 2015 Aug 24. Vaccine. 2015. PMID: 26314624

3

Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort study.

Gazaignes S, Resche-Rigon M, Gatey C, Yang C, Denis B, Fonsart J, Desseaux K, Guionie M, Rozenbaum W, Delaugerre C, Molina JM. Gazaignes S, et al. Antivir Ther. 2016;21(4):329-36. doi: 10.3851/IMP3010. Epub 2015 Nov 13. Antivir Ther. 2016. PMID: 26566057

4

[Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].

Gazaignes S, Bergeron A, Menotti J, Desseaux K, Molina JM, De Castro N. Gazaignes S, et al. Rev Mal Respir. 2020 Apr;37(4):299-307. doi: 10.1016/j.rmr.2019.12.006. Epub 2020 Apr 6. Rev Mal Respir. 2020. PMID: 32273116 French.

5

Efficacy and safety of rilpivirine-based regimens in treatment-experienced HIV-1 infected patients: a prospective cohort study.

Gazaignes S, Resche-Rigon M, Yang C, Gatey C, Munier AL, Desseaux K, Rozenbaum W, Molina JM. Gazaignes S, et al. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19796. doi: 10.7448/IAS.17.4.19796. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397540 Free PMC article.

6

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.

Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ. Lacombe JM, et al. Among authors: gazaignes s. AIDS. 2013 Feb 20;27(4):635-43. doi: 10.1097/QAD.0b013e32835cba6c. AIDS. 2013. PMID: 23196937 Free PMC article.

7

Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.

Ghislain M, Bastard JP, Meyer L, Capeau J, Fellahi S, Gérard L, May T, Simon A, Vigouroux C, Goujard C; ANRS-COPANA Cohort Study Group. Ghislain M, et al. PLoS One. 2015 Dec 4;10(12):e0144317. doi: 10.1371/journal.pone.0144317. eCollection 2015. PLoS One. 2015. PMID: 26636578 Free PMC article. Clinical Trial.

8

Pharmacokinetic study of raltegravir in HIV-infected patients with end-stage liver disease: the LIVERAL-ANRS 148 study.

Barau C, Braun J, Vincent C, Haim-Boukobza S, Molina JM, Miailhes P, Fournier I, Aboulker JP, Vittecoq D, Duclos-Vallée JC, Taburet AM, Teicher E; Agence Nationale de Recherche sur le Sida et les hépatites (ANRS) 148 Study Group. Barau C, et al. Clin Infect Dis. 2014 Oct 15;59(8):1177-84. doi: 10.1093/cid/ciu515. Epub 2014 Jul 3. Clin Infect Dis. 2014. PMID: 24992955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page